Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex
Angiogenic-Regulatory Network D iabetes is associated with microvascular rarefaction and reduced collateralization in ischemic tissues. 1,2 These circulatory deficits often lead to ischemic injury, impaired wound healing, and the development of peripheral artery disease in diabetic patients. The mouse ischemic hindlimb model is used to study angiogenic repair associated with peripheral artery disease. 3 In this model, the distal portion of the saphenous artery and major side-branches are excised, leading to vascular insufficiency. In response to this injury, there is a time-dependent increase in limb perfusion and neovascularization that can be evaluated by laser Doppler blood flow (LDBF) analysis and by assessing capillary density in tissue sections. Development of collateral vessels is a complex process requiring the action of multiple genetic programs. 4 Microarray technology provides a method for identifying novel therapeutic and diagnostic target genes in cardiovascular disease, and this technology has been used previously to analyze the expression patterns of Ϸ12 000 transcripts involved in collateral vessel formation in C57BL/6 mice. 5 Previous studies have found that ischemic hindlimb neovascularization is impaired in models of type 1 diabetes, including streptozatocin-treated rats and mice, nonobese diabetic mice, and alloxan-treated rabbits. 6 -8 Type 2 diabetes is more prevalent in industrialized regions, and it is characterized by elevations in insulin and peripheral insulin resistance. Type 2 diabetes commonly occurs in patients who are obese and display features of the metabolic syndrome. The Lepr db/db mouse is a model of obesity and type 2 diabetes mellitus. Lepr db/db mice become identifiably obese and show elevations of plasma insulin and of blood glucose because of the spontaneous mutation of the leptin receptor. 9 The current study had 2 aims. First, we tested whether a mouse model of obesity and type 2 diabetes (Lepr db/db ) displays impaired angiogenesis in hindlimbs that are made ischemic. Second, we performed DNA microarray analyses on Lepr db/db and wild-type (WT) mice before and after ischemic surgery to assess the differences in the expression profiles of angiogenesisrelated proteins to identify candidates that may account for the impaired angiogenic response in Lepr db/db mice.
Methods
For the Methods section, please see the online supplement, available at http://atvb.ahajournals.org.
Results

Impaired Ischemia-Induced Vascular Remodeling in Lepr db/db Mice
The mice analyzed in this study were C57BL/6 (WT) and Lepr db/db on the C57BL/6 background. Blood pressure did not differ between the 2 groups on the day of surgery (Table I , available online at http://atvb.ahajournals.org). Significant differences were observed in body weight, plasma glucose, and insulin and leptin levels between WT and Lepr db/db mice. All mice survived after surgical induction of left hindlimb ischemia. Figure 1A shows representative LDBF images of hindlimb blood flow before surgery, immediately after surgery, and at 14 days after surgery in the WT and Lepr db/db mice. Immediately after left femoral artery and vein resection, the ratio of blood flow between the ischemic and nonischemic hindlimbs decreased to 0.21Ϯ0.08 in WT and 0.22Ϯ0.08 in Lepr db/db mice, indicating that the severity of the induced ischemia was comparable in the 2 experimental groups. In WT mice, hindlimb blood flow perfusion increased to Ϸ75% of the nonischemic limb by day 14 ( Figure 1B ). In contrast, flow recovery in Lepr db/db mice was impaired, and the deficits in flow were statistically significant at 14, 28, and 35 days after surgery.
To investigate the extent of vascular remodeling at the level of the microcirculation in WT or Lepr db/db mice, quantitative analysis of capillary density in ischemic and contralateral adductor muscle of WT and Lepr db/db mice was determined in histological sections harvested on postoperative day 14. Quantitative analysis of CD31-positive cells revealed that the ischemia-induced increase in capillary density in the ischemic limb relative to the contralateral limb was essentially absent in Lepr db/db mice (Figure 2 ), indicative of an impaired angiogenic response in these animals. At the 14-day time point after surgery, the ischemic adductor muscle of Lepr db/db mice had significantly fewer CD31-positive cells compared with ischemic muscle from WT mice.
Transcript Expression Before and After Hindlimb Ischemia in WT and Lepr db/db Mice
Transcript expression profiles in WT and Lepr db/db mice were analyzed before surgery and 1, 7, and 14 days after surgery. RNA was isolated from normal or ischemic adductor muscles and hybridized to Affymetrix GeneChip Mouse Expression Set microarray 2.0 (Ϸ45 000 cDNAs and ESTs). Transcript level differences between WT and Lepr db/db mice at the same time point, or between different time points for the same mouse strain, were deemed statistically significant if the fold change difference was Ͼ2.0 (nϭ3; PϽ0.01). This analysis revealed 356 transcripts that were differentially regulated between WT and Lepr db/db mice before surgery. At 1, 7, and 14 days after surgery, 683, 3362, and 3128 transcripts, respectively, were differentially regulated compared with presurgery in WT mice. In Lepr db/db mice, 979, 310, and 1371 transcripts were differentially regulated at days 1, 7, and 14 respectively, compared with presurgery. Of note, many of the genes differentially expressed in Lepr db/db mice were not detected in the data set from WT mice. At the 14-day time point, 66% of genes detected as differentially expressed in Lepr db/db mice were not detected as differentially expressed in WT mice ( Figure 3A) . Similarly, 74% and 87% of differentially expressed transcripts in Lepr db/db mice were not detected as differentially expressed in WT mice at days 7 and 1 after surgery, respectively. Thus, although fewer genes are differentially expressed in Lepr db/db mice, they do not appear to simply represent a subset of genes regulated in WT. Instead, most of the transcripts regulated in Lepr db/db mice after ischemic surgery represent a different set of genes.
An automated analysis of related transcripts was performed using Ingenuity Pathways Analysis software. For this analysis, a set of 3128 transcripts differentially expressed in WT mice at day 14 compared with baseline (presurgery; fold change Ͼ2.0 or Ͻ2.0; PϽ0.01) was used as the starting point for generating biological networks. This time point was chosen because it was the earliest to achieve statistical significance in the LDBF analysis ( Figure 1) . One of the networks achieved a score of 27 and consisted of 35 transcripts, of which 34 were differentially regulated at 14 days after surgery ( Figure 3B) . A key providing transcript identity for this network and its fold change is provided in Table 1 . These transcripts included the angiogenesis-regulatory factors vascular endothelial growth factor-A (VEGF-A), neuropilin-1, neuropilin-2, placental growth factor, and the putative transcriptional regulators of neuropilin-1, the HHEX homeobox factor. 10 In contrast to the identification that a number of proangiogenic transcripts were upregulated, VEGF-B and RORC, a transcriptional regulator of VEGF-A, 11 were downregulated. Other differentially expressed transcripts in this network included 3 proteasome subunits, translation regulatory factors (EIF4E, EIF4EBP2, and ETFI), the proteases cathepsin S and lysozyme, and a number of metalloproteinases (matrix metalloproteinase-2 [MMP2], MMP12, MMP16). In addition, the matrix proteins elastin, SPARC, and myelin basic protein (MBP), and 5 protein kinases that phosphorylate MBP, were upregulated in the ischemic hindlimbs of WT mice. Once established, the 1371 transcripts differentially expressed in Lepr db/db mice at day 14 were superimposed on this network ( Figure 3C ; Table II , available online at http://atvb.ahajournals.org). Only 10 differentially regulated transcripts were observed in Lepr db/db mice compared with 34 in WT mice. Of note, differentially regulated transcripts observed in WT but not in Lepr db/db mice included the angiogenesis growth factors and neuropilin coreceptors elastin and the MMPs.
A number of transcripts within the network were also identified as differentially regulated at earlier time points. In ; gray, transcripts differentially regulated in both strains. B, Network constructed from differentially regulated transcripts comparing microarray data from the hindlimbs of WT mice at baseline and 14 days after surgery. The network score was 27. Shaded genes were identified as differentially expressed by the extent of shading that is indicative of the magnitude of regulation. Red shading indicates upregulation at day 14 relative to baseline, whereas green shading indicates downregulation. Node shapes indicate function; diamond, an enzyme; square, growth factor; triangle, kinase; circle, other. Asterisk indicates transcripts identified multiple times on the microarray; line, physical interactions (eg, formation of complexes); arrow, functional interaction (activation); ٜ, functional interaction (inhibition). C, Transcripts differentially regulated in Lepr db/db mice comparing baseline and day 14 after surgery superimposed on the network constructed for WT mice as described in B.
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WT mice, ELN, NRP1, and EIF4E were detected as differentially regulated at day 1 after surgery, and CLK2, CTSS, EIF4E, EIF4EBP2, HHEX, HSPB8, LYZ, MBP, MMP16, NID, NRP1, NRP2, PAK3, PSMB7, RGS2, RORC, SPARC, tissue factor pathway inhibitor, tissue inhibitor of metalloproteinases-4 (TIMP4), VEGF-A, and VRK1 were detected as differentially regulated at 7 days. In contrast, in Lepr db/db mice, only RGS2 was identified as differentially regulated at 1 day, and MBP and TIMP4 were identified as differentially regulated at 7 days.
The 356 transcripts identified as differentially expressed between WT and Lepr db/db mice before surgery (fold change Ͼ2.0 or Ͻ2.0; PϽ0.01) were superimposed on this network (data not shown). No differentially expressed transcripts were observed in the network, demonstrating that the differences observed between WT and Lepr db/db mice reflected a differential response of the tissues to ischemic injury rather than a baseline difference presurgery. Finally, other networks were identified using the Ingenuity software (Please see online supplement, available at http://atvb.ahajournals.org).
Quantitative RT-PCR of Selected Transcripts
The differential expression of 3 angiogenesis-related transcripts identified by the microarray and pathway analyses were examined in greater detail by quantitative RT-PCR (QRT-PCR) using the primer sets listed in supplemental Table III (available online at http://atvb.ahajournals.org). The representative transcripts chosen for this analysis were elastin, the main component of the extracellular matrix of arteries, neuropilin-1, a coreceptor for VEGF receptor 2 (VEGF-R2), 12 and VEGF-A, a major angiogenic factor. Consistent with the microarray data, little or no difference in the levels of these transcripts were apparent before surgery in the limbs of WT and Lepr db/db mice ( Table 2) . QRT-PCR assays showed that these transcripts were upregulated at 1, 7, and 14 days after surgery (elastin and neuropilin-1) or at 7 and 14 days after surgery (VEGF-A) in WT mice. However, elastin, neuropilin-1, or VEGF-A upregulation was not observed in the Lepr db/db mice on days 1, 7, or 14 after surgery, consistent with the findings of the microarray data.
Elastin and Neuropilin-1 Protein Expression in Ischemic Muscle After Hindlimb Ischemia
Elastin and neuropilin-1, 2 factors involved in arterial morphogenesis or angiogenesis, were also analyzed by Western immunoblot analysis in WT and Lepr db/db mice. Elastin and neuropilin-1 transcripts were identified as differentially expressed at 1, 7, and 14 days in WT but not Lepr db/db mice. Immunoblotting for elastin in samples from muscle tissue of Lepr db/db and WT mice before hindlimb ischemia surgery and on days 1, 7, and 14 after surgery showed an upregulation in WT mice, whereas no upregulation was detected in the ischemic limbs of Lepr db/db mice ( Figure 4A ). Immunoblotting also revealed an increase in the neuropilin-1 content of the ischemic muscle tissue in WT mice after hindlimb ischemia, in accordance with the microarray and QRT-PCR data. In contrast, the increase in neuropilin-1 protein content after ischemic muscle tissue of Lepr db/db mice was considerably lower ( Figure 4B ).
Discussion
Diabetes and obesity promote microvascular rarefaction and diminish collateral vessel development in the heart and peripheral tissues. 1, 2 The Lepr db/db mouse is a model of type 2 diabetes that results from a leptin receptor deficiency. Here we show that the angiogenic repair of ischemic hindlimbs is impaired in Lepr db/db mice compared with C57BL/6 (WT) mice, as evaluated by laser Doppler flow and capillary density analyses. These data are consistent with observations of diminished skin wound healing in these animals. [13] [14] [15] Here it is also shown that the impairment is associated with alterations in a gene regulatory network involved in the physiological revascularization process. Microarray analysis revealed alterations in the expression patterns of numerous None of the transcripts identified in this network were found to be differentially expressed between these 2 mouse lines at baseline (data not shown). These data indicate that the Lepr db/db mouse fails to correctly activate a multifaceted angiogenic program in response to ischemic injury.
Analysis of the microarray data reveals that fewer transcripts are differentially expressed in the ischemic limbs of Lepr db/db mice than WT mice at days 7 and 14 after surgery. Comparison of the data sets indicate that most of the genes identified as differentially regulated in Lepr db/db mice do not represent a subset of the genes regulated in WT mice. Instead, the majority of transcripts represent a distinct set of genes that are differentially regulated in WT and Lepr db/db mice. In this regard, leptin has been recognized as a proangiogenic molecule that displays synergistic effects with fibroblast growth factor-2 and VEGF in promoting blood vessel growth. 16, 17 Although leptin deficiency may be directly responsible for some of the changes in the angiogenic program of Lepr db/db mice, the diabetes and obesity that develop as a consequence of leptin deficiency is also likely to have a profound impact on the angiogenesis-regulatory network in this model.
Our experiments showed that transcripts for MMP2, MMP12, or MMP16 were upregulated in WT mice after hindlimb ischemia, but this response was suppressed in Lepr db/db mice. These data also revealed the downregulation of TIMP4, a negative regulator of MMP2, in WT and Lepr db/db mice. Metalloproteinases hydrolyze components of the extracellular matrix, creating the cellular environments required during development or morphogenesis. 18 MMPs are important regulators of angiogenesis by virtue of their abilities to allow endothelial cell migration through the degradation of matrix and to activate latent cytokines and growth factors. In this regard, MMP2 cleaves SPARC, a protein implicated in tumor progression and angiogenesis, 19, 20 and it has been proposed that SPARC cleavage can yield proangiogenic peptides. 21 Like MMP2, SPARC transcripts are upregulated in the ischemic limbs of WT but not Lepr db/db mice. Less is known about the proangiogenic activities of MMP12 and MMP16, but MMP12 has been implicated in macrophage migration, 22 and MMP16 promotes the cleavage and activation of MMP2. 23 The microarray, QRT-PCR, and Western immunoblot analyses revealed upregulation of elastin in WT but not Lepr db/db mice. Elastin is the main component of the extracellular matrix of arteries, and it performs a regulatory function during arterial morphogenesis and development by controlling proliferation of smooth muscle and stabilizing the arterial structure. 24 In diabetic animals, the elasticity of this protein is reduced as a result of increased glycosylation, leading to the accumulation and reorganization of smooth muscle cells. 25 In addition, the involvement of elastin derived peptides in angiogenesis has been reported. 26 These proangiogenic fragments of elastin can be produced by the proteolytic actions of MMPs, including MMP2. Elastin is also cleaved by cathepsin S and MMP12, 27, 28 which are upregulated in the ischemic hindlimbs of WT but not Lepr db/db mice. In addition to the dysregulation of extracellular matrix, impaired regulation of a number of angiogenic growth factors and growth factor receptors were differentially regulated in the ischemic limbs of WT and Lepr db/db mice. Microarray data showed that VEGF-A, placental growth factor, neuropilin-1, and neuropilin-2 were upregulated in WT mice after surgery, but this regulation was impaired in Lepr db/db mice. VEGF-A is a key hypoxia-inducible angiogenic factor that induces the proliferation, migration, and survival of endothelial cells, 29 and also promotes the expression of proteases implicated in pericellular matrix degradation in angiogenesis. 30 Activation of VEGF-R1 by either VEGF-A or placental growth factor induces different gene expression profiles and promotes the phosphorylation of distinct tyrosine residues in the tyrosine kinase domain of VEGF-R1, and the combined administration of these factors enhances VEGF driven angiogenesis. 31 Neuropilin-1 and neuropilin-2 are cell-surface glycoproteins that participate in the regulation of angiogenesis. 32 Neuropilin-1 functions as a coreceptor for VEGF-R2 that enhances the activity of VEGF-A in ischemic tissues. 12 An unexpected finding of this study is the observation that MBP and a series of protein kinases that phosphorylate this protein are upregulated in the ischemic limbs of WT but not Lepr db/db mice. MBP is also cleaved by MMP2. 33 MBP functions in maintaining the structural integrity of the myelin sheath, and it is subjected to a wide array of post-translational modifications. 34 Thus, the impaired induction of MBP and its regulatory network in Lepr db/db mice may contribute to the peripheral neuropathy that is associated with peripheral vascular disease. 35 There has been considerable interest in "therapeutic angiogenesis" because many patients are not amenable to traditional forms of revascularization. 36 However, despite a large number of positive preclinical studies, the results of controlled therapeutic angiogenesis trials have been largely negative. One reason that may account for the lack of clinical success is that preclinical studies are almost exclusively performed on healthy, young animals that exhibit robust angiogenic responses, whereas the patient population experiences a high incidence of obesity and insulin-resistant diabetes. Therefore, we used a mouse model of type 2 diabetes and obesity to study revascularization after ischemic injury. Lepr db/db mice displayed functional and anatomic deficits in hindlimb revascularization that was associated with the dysregulation of a complex angiogenesis-regulatory network. These data suggest that a single angiogenic agent may not be sufficient to effectively stimulate angiogenesis in subjects with insulin-resistant diabetes and that the control of obesity and its associated diseases may improve the success of proangiogenic therapies.
Methods Materials
Neuropilin-1 and elastin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Tubulin antibody was purchased from Oncogene (Cambridge, MA, USA).
Mouse model
Lepr db/db mice in a C57/BL6 background and wild-type (WT) C57/BL6 mice purchased from the Jackson Laboratory were used for this study. Study protocols were approved by the Institutional Animal Care and Use Committee in Boston University. Mice were subjected to unilateral hind limb surgery under anesthesia with sodium pentobarbital (50 mg/kg intraperitoneally). An incision was made in the skin overlying the middle portion of the left hind limb. After ligation of the proximal end of the femoral artery and the distal portion of the saphenous artery, the artery and side-branches were dissected free and excised. 1, 2 Before surgery body weight (BW) and systolic blood pressure (sBP) were determined using a tail-cuff pressure analysis system in the conscious state.
Laser Doppler blood flow analysis
Hind limb blood flow was measured using a laser Doppler blood flow (LDBF analyzer (Moor LDI; Moor Instruments, Devon, United Kingdom). Immediately before surgery and on postoperative days 1, 7, 14, 28 and 35, LDBF analysis were performed on legs and feet. Blood flow was displayed as changes in the laser frequency using different color pixels. After scanning, stored images were analyzed to quantify blood flow. To avoid data variations, hind limb blood flow was expressed as the ratio of left (ischemic) to right (nonischemic) limb.
Serum measurement
Blood samples were collected on the day of surgery. Glucose was measured with an enzymatic kit (Wako Chemicals, Richmond, VA, USA), leptin levels were measured with a Mouse Leptin ELISA kit (Crystal CHEM INC, Downers Grove, IL, USA) and insulin levels were assayed with an EIA kit (Wako Chemicals, Richmond, VA, USA).
Tissue preparation and immunohistochemistry
The mice were sacrificed at time points before or after surgery with an overdose of sodium pentobarbital. For total protein or RNA extraction, isolated tissue samples were Gene expression data was obtained for adductor muscle in the ischemic limb from Lepr db/db mice and wild type mice at each of 4 time points (before hind limb ischemia, 1 day, 7 days and 14 days after hind limb ischemia surgery). Three independent experimental replicates of each condition for each time point were performed.
Data quantification, normalization and analysis
Following data acquisition, the scanned images were quantified using MAS 5.0 software An automated analysis of related transcripts was performed using Ingenuity Pathways Analysis, a web-delivered application that evaluates biological networks (www.ingenuity.com). For this analysis a set of 3129 gene identifiers revealed as significantly changed in WT mice on day 14 compared to baseline (pre-surgery) (fold change >/<2.0, p<0.01) was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base that is derived from information in the scientific literature.
These Focus Genes were then used for generating biological networks based upon the identities of the Focus Genes and interactions with genes/proteins that are reported in the literature. The software computes a score for each network according to the fit of the Focus Genes that were significantly changed in Lepr db/db and WT mice between 14 days and pre-surgery using a Fischer's exact test. The score is derived from a p-value and indicates the likelihood of the Focus Genes in a network being found together due to random chance. A score of 2 indicates that there is a 1% chance that the Focus Genes are together in a network due to random chance. Therefore, scores of ≥2 have ≥99%
confidence (and ≥3 have ≥99.9%) of not being generated by random chance alone.
QRT-PCR analysis
Total RNA was isolated and purified from the ischemic muscle in the ischemic limb as Accumulation of PCR product was monitored in real time (PE-Applied Biosystems), and the crossing threshold (Ct) was determined using the PE-Applied Biosystems software.
For each set of primers, a no template control and a no reverse amplification control were included. Postamplification dissociation curves were performed to verify the presence of a single amplification product in the absence of DNA contamination. Fold changes in transcript expression were determined using the Ct method. To standardize the quantitation of the selected transcripts, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) from each sample was quantified by QRT-PCR and the selected transcripts were normalized to GAPDH. Data of QRT-PCR analysis are shown as the means ± S.E. of mean. All data were evaluated with a two-tailed, unpaired
Student's t test or compared by one-way analysis of variance (p<0.01).
Western Blot Analysis
Tissue samples obtained before surgery and at days 1, 7 and 14 post-surgery were 
